| Literature DB >> 28622385 |
Patrick R Secor1, Gabriele Sass2, Hasan Nazik2,3,4, David A Stevens2,3.
Abstract
In persons with structural lung disease, particularly those with cystic fibrosis (CF), chronic airway infections cause progressive loss of lung function. CF airways can be colonized by a variety of microorganisms; the most frequently encountered bacterial and fungal pathogens are Pseudomonas aeruginosa and Aspergillus fumigatus, respectively. Co-infection with P. aeruginosa and A. fumigatus often results in a more rapid loss of lung function, indicating that interactions between these pathogens affect infection pathogenesis. There has been renewed interest in the use of viruses (bacteriophage, mycoviruses) as alternatives to antibiotics to treat these infections. In previous work, we found that filamentous Pf bacteriophage produced by P. aeruginosa directly inhibited the metabolic activity of A. fumigatus by binding to and sequestering iron. In the current study, we further examined how filamentous Pf bacteriophage affected interactions between P. aeruginosa and A. fumigatus. Here, we report that the antifungal properties of supernatants collected from P. aeruginosa cultures infected with Pf bacteriophage were substantially less inhibitory towards A. fumigatus biofilms. In particular, we found that acute infection of P. aeruginosa by Pf bacteriophage inhibited the production of the virulence factor pyoverdine. Our results raise the possibility that the reduced production of antimicrobials by P. aeruginosa infected by Pf bacteriophage may promote conditions in CF airways that allow co-infection with A. fumigatus to occur, exacerbating disease severity. Our results also highlight the importance of considering how the use of bacteriophage as therapeutic agents could affect the behavior and composition of polymicrobial communities colonizing sites of chronic infection.Entities:
Mesh:
Year: 2017 PMID: 28622385 PMCID: PMC5473581 DOI: 10.1371/journal.pone.0179659
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Bacterial strains, plasmids, and PCR primers used in this study.
| Strain or plasmid | Genotype, description, or sequence | Source |
|---|---|---|
| PAO1 | Wild type | [ |
| PAK | Wild type | ATCC 25102 |
| | PAO1 Δ | This study |
| 10AF | A virulent Af strain | [ |
| Bacteriophage | ||
| Pf4 | Isolated from PAO1 biofilm | [ |
| Pf1 | Pf phage that infects PAK | ATCC 25102-B1 |
| Plasmids | ||
| pDONRpEX18Gm | pEX18Gm with Gateway donor site | [ |
| pDONRpEX18Gm:: | Deletion construct targeting | This study |
| Primers | ||
| PA0723F01-GWB1 | This study | |
| PA0723R01 | This study | |
| PA0723F01 | This study | |
| PA0723R01-GWB2 | This study | |
| PA0723 seq-F | This study | |
| PA0723 seq-R | This study | |
| M13F(-21) | ||
| M13R | ||
| Pf4F | [ | |
| Pf4R | [ |